CN101830965A - 金属离子催化水解天然苷类化合物的方法 - Google Patents
金属离子催化水解天然苷类化合物的方法 Download PDFInfo
- Publication number
- CN101830965A CN101830965A CN 201010170521 CN201010170521A CN101830965A CN 101830965 A CN101830965 A CN 101830965A CN 201010170521 CN201010170521 CN 201010170521 CN 201010170521 A CN201010170521 A CN 201010170521A CN 101830965 A CN101830965 A CN 101830965A
- Authority
- CN
- China
- Prior art keywords
- metal ion
- nucleoside compound
- saponin
- natural nucleoside
- catalyzing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 nucleoside compound Chemical class 0.000 title claims abstract description 56
- 229910021645 metal ion Inorganic materials 0.000 title claims abstract description 27
- 239000002777 nucleoside Substances 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 23
- 230000003301 hydrolyzing effect Effects 0.000 title claims abstract description 15
- 229930182490 saponin Natural products 0.000 claims abstract description 76
- 235000017709 saponins Nutrition 0.000 claims abstract description 76
- 150000007949 saponins Chemical class 0.000 claims abstract description 72
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims abstract description 59
- 229930182470 glycoside Natural products 0.000 claims abstract description 19
- 229930182486 flavonoid glycoside Natural products 0.000 claims abstract description 16
- 150000007955 flavonoid glycosides Chemical class 0.000 claims abstract description 16
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 150000002338 glycosides Chemical class 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 60
- 238000006243 chemical reaction Methods 0.000 claims description 56
- 238000006460 hydrolysis reaction Methods 0.000 claims description 34
- 125000003147 glycosyl group Chemical group 0.000 claims description 27
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 24
- 239000011347 resin Substances 0.000 claims description 18
- 229920005989 resin Polymers 0.000 claims description 18
- 239000003463 adsorbent Substances 0.000 claims description 17
- 238000000605 extraction Methods 0.000 claims description 17
- 238000005406 washing Methods 0.000 claims description 17
- 238000010521 absorption reaction Methods 0.000 claims description 16
- 239000000413 hydrolysate Substances 0.000 claims description 16
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 claims description 13
- 229930191447 pulchinenoside Natural products 0.000 claims description 12
- KNJZSRUBTKLEDR-FXRKFYLMSA-N 3beta-O-{alpha-L-Rhap-(1->2)-beta-D-Glcp-(1->4)-[beta-D-Glcp-(1->2)]-alpha-L-Arap}primulagenin A Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H](O[C@@H]3C([C@H]4[C@]([C@@H]5[C@@]([C@@]6(C[C@@H](O)[C@@]7(CO)CCC(C)(C)C[C@H]7C6=CC5)C)(C)CC4)(C)CC3)(C)C)OC2)O)O[C@H](CO)[C@@H](O)[C@@H]1O KNJZSRUBTKLEDR-FXRKFYLMSA-N 0.000 claims description 10
- CJNUQCDDINHHHD-APRUHSSNSA-N dioscin Natural products C[C@@H]1CC[C@@]2(OC1)O[C@H]3C[C@H]4[C@@H]5CC=C6C[C@H](CC[C@@H]6[C@H]5CC[C@]4(C)[C@H]3[C@@H]2C)O[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O[C@@H]9O[C@@H](C)[C@H](O)[C@@H](O)[C@H]9O CJNUQCDDINHHHD-APRUHSSNSA-N 0.000 claims description 10
- 239000000758 substrate Substances 0.000 claims description 10
- HDXIQHTUNGFJIC-UHFFFAOYSA-N (25R)-spirost-5-en-3beta-ol 3-O-<O-alpha-L-rhamnopyranosyl-(1-->2)-beta-D-glucopyranoside> Natural products O1C2(OCC(C)CC2)C(C)C(C2(CCC3C4(C)CC5)C)C1CC2C3CC=C4CC5OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O HDXIQHTUNGFJIC-UHFFFAOYSA-N 0.000 claims description 9
- VNONINPVFQTJOC-RXEYMUOJSA-N Collettiside III Natural products O([C@@H]1[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O2)[C@H](CO)O[C@@H]1O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]5[C@H](C)[C@@]6(O[C@H]5C4)OC[C@H](C)CC6)CC3)CC=2)CC1)[C@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O1 VNONINPVFQTJOC-RXEYMUOJSA-N 0.000 claims description 9
- VNONINPVFQTJOC-ZGXDEBHDSA-N dioscin Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]([C@]1(OC[C@H](C)CC1)O5)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O VNONINPVFQTJOC-ZGXDEBHDSA-N 0.000 claims description 9
- VNONINPVFQTJOC-UHFFFAOYSA-N polyphyllin III Natural products O1C2(OCC(C)CC2)C(C)C(C2(CCC3C4(C)CC5)C)C1CC2C3CC=C4CC5OC(C(C1O)OC2C(C(O)C(O)C(C)O2)O)OC(CO)C1OC1OC(C)C(O)C(O)C1O VNONINPVFQTJOC-UHFFFAOYSA-N 0.000 claims description 9
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 claims description 7
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 claims description 7
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 claims description 7
- 239000009636 Huang Qi Substances 0.000 claims description 7
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 claims description 7
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 claims description 7
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 claims description 7
- 229940025878 hesperidin Drugs 0.000 claims description 7
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 claims description 7
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 claims description 7
- 229930019673 naringin Natural products 0.000 claims description 7
- 229940052490 naringin Drugs 0.000 claims description 7
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 claims description 6
- 229930187479 gypenoside Natural products 0.000 claims description 6
- 229930190017 ophiopogonin Natural products 0.000 claims description 6
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 claims description 6
- HDDDNIUXSFCGMB-UHFFFAOYSA-N quercetin 3-galactoside Natural products OCC1OC(OC2=C(Oc3ccc(O)c(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C(O)C1O HDDDNIUXSFCGMB-UHFFFAOYSA-N 0.000 claims description 6
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical group O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 claims description 6
- 229960004555 rutoside Drugs 0.000 claims description 6
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims description 5
- 238000006555 catalytic reaction Methods 0.000 claims description 5
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims description 5
- ZRBFCAALKKNCJG-UHFFFAOYSA-N gypenoside-XVII Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O ZRBFCAALKKNCJG-UHFFFAOYSA-N 0.000 claims description 5
- BBEUDPAEKGPXDG-UHFFFAOYSA-N protopanaxatriol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC3C4(C)CCC(O)C(C)(C)C4C(O)CC23C BBEUDPAEKGPXDG-UHFFFAOYSA-N 0.000 claims description 5
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims description 5
- 235000005493 rutin Nutrition 0.000 claims description 5
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims description 5
- 241000893536 Epimedium Species 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 239000004378 Glycyrrhizin Substances 0.000 claims description 2
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 claims description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 2
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 claims description 2
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 claims description 2
- 229960003321 baicalin Drugs 0.000 claims description 2
- 235000018905 epimedium Nutrition 0.000 claims description 2
- 229930003944 flavone Natural products 0.000 claims description 2
- 235000011949 flavones Nutrition 0.000 claims description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 2
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 2
- 235000008696 isoflavones Nutrition 0.000 claims description 2
- SHCBCKBYTHZQGZ-DLHMIPLTSA-N protopanaxatriol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2[C@@H](O)C[C@@]3(C)[C@]4(C)CC[C@H]([C@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C SHCBCKBYTHZQGZ-DLHMIPLTSA-N 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000000047 product Substances 0.000 abstract description 22
- 150000004676 glycans Chemical class 0.000 abstract description 11
- 229920001282 polysaccharide Polymers 0.000 abstract description 11
- 239000005017 polysaccharide Substances 0.000 abstract description 11
- 239000003814 drug Substances 0.000 abstract description 6
- 229930183217 Genin Natural products 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 239000002778 food additive Substances 0.000 abstract 1
- 235000013373 food additive Nutrition 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 description 30
- 239000003643 water by type Substances 0.000 description 26
- 230000003197 catalytic effect Effects 0.000 description 16
- 238000001035 drying Methods 0.000 description 15
- 239000012535 impurity Substances 0.000 description 15
- 238000010828 elution Methods 0.000 description 14
- 238000002156 mixing Methods 0.000 description 14
- 238000003756 stirring Methods 0.000 description 14
- 239000002585 base Substances 0.000 description 10
- 238000000746 purification Methods 0.000 description 9
- 238000000926 separation method Methods 0.000 description 8
- 238000004809 thin layer chromatography Methods 0.000 description 8
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229960001866 silicon dioxide Drugs 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 239000000178 monomer Substances 0.000 description 5
- 150000002772 monosaccharides Chemical group 0.000 description 5
- 230000000857 drug effect Effects 0.000 description 4
- 229960001587 hesperetin Drugs 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 3
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 229960001285 quercetin Drugs 0.000 description 3
- 235000005875 quercetin Nutrition 0.000 description 3
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RWXIFXNRCLMQCD-JBVRGBGGSA-N (20S)-ginsenoside Rg3 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RWXIFXNRCLMQCD-JBVRGBGGSA-N 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- 244000281702 Dioscorea villosa Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- QMNWISYXSJWHRY-YLNUDOOFSA-N astragaloside IV Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)[C@H]4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C[C@H]3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-YLNUDOOFSA-N 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- PFKIBRPYVNVMRU-UHFFFAOYSA-N cyclosieversioside F Natural products CC(C)(O)C1COC(C)(C1)C2C(O)CC3(C)C4CC(OC5OC(CO)C(O)C(O)C5O)C6C(C)(C)C(CCC67CC47CCC23C)OC8OCC(O)C(O)C8O PFKIBRPYVNVMRU-UHFFFAOYSA-N 0.000 description 2
- IWUMQCYNYDYUKR-UHFFFAOYSA-N cyclosiversioside F Natural products CC(C)(O)C1CCC(C)(O1)C2C(O)CC3C4CC(OC5OC(CO)C(O)C(O)C5O)C6C(C)(C)C(CCC67CC47CCC23C)OC8OCC(O)C(O)C8O IWUMQCYNYDYUKR-UHFFFAOYSA-N 0.000 description 2
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- AIONOLUJZLIMTK-AWEZNQCLSA-N hesperetin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000007625 naringenin Nutrition 0.000 description 2
- NWMIYTWHUDFRPL-UHFFFAOYSA-N sapogenin Natural products COC(=O)C1(CO)C(O)CCC2(C)C1CCC3(C)C2CC=C4C5C(C)(O)C(C)CCC5(CCC34C)C(=O)O NWMIYTWHUDFRPL-UHFFFAOYSA-N 0.000 description 2
- FBFMBWCLBGQEBU-RXMALORBSA-N (2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-2-[[(3s,5r,6s,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2s)-6-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecah Chemical class O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FBFMBWCLBGQEBU-RXMALORBSA-N 0.000 description 1
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 1
- HPVKSGLGOKNQON-UHFFFAOYSA-N 3-O-(beta-D-galactopyranosyl-(1->3)-beta-D-glucopyranosyl)serjanic acid 28-O-beta-D-glucopyranoside Natural products COC(=O)C1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OC(CO)C(O)C(OC7OC(CO)C(O)C(O)C7O)C6O)C(C)(C)C5CCC34C)C2C1)C(=O)OC8OC(CO)C(O)C(O)C8O HPVKSGLGOKNQON-UHFFFAOYSA-N 0.000 description 1
- HLLSOEKIMZEGFV-UHFFFAOYSA-N 4-(dibutylsulfamoyl)benzoic acid Chemical compound CCCCN(CCCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 HLLSOEKIMZEGFV-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 235000000504 Dioscorea villosa Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 description 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 description 1
- 241000168720 Panax japonicus Species 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 229930194300 Trillenoside Natural products 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 1
- 229940117954 naringenin Drugs 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- ARGKVCXINMKCAZ-UZRWAPQLSA-N neohesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UZRWAPQLSA-N 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010170521 CN101830965B (zh) | 2010-05-13 | 2010-05-13 | 金属离子催化水解天然苷类化合物的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010170521 CN101830965B (zh) | 2010-05-13 | 2010-05-13 | 金属离子催化水解天然苷类化合物的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101830965A true CN101830965A (zh) | 2010-09-15 |
CN101830965B CN101830965B (zh) | 2013-01-16 |
Family
ID=42715202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010170521 Active CN101830965B (zh) | 2010-05-13 | 2010-05-13 | 金属离子催化水解天然苷类化合物的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101830965B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105218611A (zh) * | 2015-08-31 | 2016-01-06 | 金凤燮 | 第20碳羟基脱水的人参稀有皂苷和苷元的制备方法 |
CN107501376A (zh) * | 2017-08-11 | 2017-12-22 | 鱼红闪 | 金属离子催化制备人参25碳‑羟基苷元和稀有皂苷的方法 |
CN107663528A (zh) * | 2017-04-10 | 2018-02-06 | 吉林农业大学 | 一种Cu2+离子促进多粘类芽孢杆菌转化人参皂苷的方法 |
CN107955055A (zh) * | 2017-12-04 | 2018-04-24 | 鱼红闪 | 金属离子催化制备20-烯25-羟基人参稀有皂苷和苷元的方法 |
CN108467419A (zh) * | 2018-03-23 | 2018-08-31 | 四川天添生物科技应用有限公司 | 一种用芦丁合成异槲皮苷的方法 |
CN110229208A (zh) * | 2019-06-26 | 2019-09-13 | 吉林农业大学 | 一种化合物20(R)-人参皂苷Rg3的高效制备分离方法 |
CN112679564A (zh) * | 2021-02-02 | 2021-04-20 | 吉林农业大学 | 一种人参特有化合物精氨酸糖苷af的分离纯化新方法 |
CN113801758A (zh) * | 2021-09-22 | 2021-12-17 | 劲牌有限公司 | 一种降低保健酒生产过程总皂苷损耗和延缓货架期总皂苷衰减的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2182906C1 (ru) * | 2001-07-13 | 2002-05-27 | Институт химии и химической технологии СО РАН | Способ получения кверцетина |
CN1850852A (zh) * | 2006-05-16 | 2006-10-25 | 郑州大学 | 一种薯蓣皂素的无废水生产方法 |
-
2010
- 2010-05-13 CN CN 201010170521 patent/CN101830965B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2182906C1 (ru) * | 2001-07-13 | 2002-05-27 | Институт химии и химической технологии СО РАН | Способ получения кверцетина |
CN1850852A (zh) * | 2006-05-16 | 2006-10-25 | 郑州大学 | 一种薯蓣皂素的无废水生产方法 |
Non-Patent Citations (6)
Title |
---|
《亚太传统医药》 20081130 许志超 绞股蓝总皂苷水解产物中稀有抗肿瘤活成分的化学研究 41-43页 1-4 第4卷, 第11期 * |
《化学反应工程与工艺》 20061231 朱宪 近临界水中薯蓣皂苷的水解反应 502-506页 1-4 第22卷, 第6期 * |
《化学工程》 20071231 李谦 微波强化薯蓣皂苷水解的研究 30-33页 1-4 第35卷, 第12期 * |
《应用化学》 20090430 李谦 离子交换树脂催化属于皂苷水解 431-434 1-4 第26卷, 第4期 * |
《武汉工业学院学报》 20040630 韦一良 金属离子教书催化吡啶甲酸对硝基苯酚酯水解 49-53页 1-4 第23卷, 第2期 * |
《黑龙江医药科学》 20010831 张宇 黄芪总皂苷水解为黄芪甲苷的工艺研究 136-137页 1-4 第24卷, 第4期 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105218611A (zh) * | 2015-08-31 | 2016-01-06 | 金凤燮 | 第20碳羟基脱水的人参稀有皂苷和苷元的制备方法 |
CN105218611B (zh) * | 2015-08-31 | 2017-05-17 | 金凤燮 | 第20碳羟基脱水的人参稀有皂苷和苷元的制备方法 |
CN107663528A (zh) * | 2017-04-10 | 2018-02-06 | 吉林农业大学 | 一种Cu2+离子促进多粘类芽孢杆菌转化人参皂苷的方法 |
CN107501376A (zh) * | 2017-08-11 | 2017-12-22 | 鱼红闪 | 金属离子催化制备人参25碳‑羟基苷元和稀有皂苷的方法 |
CN107501376B (zh) * | 2017-08-11 | 2019-08-30 | 鱼红闪 | 金属离子催化制备人参25碳-羟基苷元和稀有皂苷的方法 |
CN107955055A (zh) * | 2017-12-04 | 2018-04-24 | 鱼红闪 | 金属离子催化制备20-烯25-羟基人参稀有皂苷和苷元的方法 |
CN108467419A (zh) * | 2018-03-23 | 2018-08-31 | 四川天添生物科技应用有限公司 | 一种用芦丁合成异槲皮苷的方法 |
CN110229208A (zh) * | 2019-06-26 | 2019-09-13 | 吉林农业大学 | 一种化合物20(R)-人参皂苷Rg3的高效制备分离方法 |
CN112679564A (zh) * | 2021-02-02 | 2021-04-20 | 吉林农业大学 | 一种人参特有化合物精氨酸糖苷af的分离纯化新方法 |
CN112679564B (zh) * | 2021-02-02 | 2021-08-13 | 吉林农业大学 | 一种人参特有化合物精氨酸糖苷af的分离纯化方法 |
CN113801758A (zh) * | 2021-09-22 | 2021-12-17 | 劲牌有限公司 | 一种降低保健酒生产过程总皂苷损耗和延缓货架期总皂苷衰减的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101830965B (zh) | 2013-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101830965B (zh) | 金属离子催化水解天然苷类化合物的方法 | |
ES2615752T3 (es) | Método de extracción de polisacáridos de plantas superiores y hongos mediante tratamiento químico por microondas | |
CN1105781C (zh) | 酶法改变人参皂甙糖基制备人参皂甙的方法 | |
Zhu et al. | Synthesis of the diverse glycosides in traditional Chinese medicine | |
CN103142669B (zh) | 酶法提取人参皂苷的方法 | |
CN107338280B (zh) | 一种低糖基人参次苷群及其苷元的制备方法 | |
CN102094052B (zh) | 一种糖苷酶催化与盐析萃取偶联制备天然药物的方法 | |
CN103520275B (zh) | 一种氧化石墨烯-乙醇协同提取黄芩总黄酮的方法 | |
CN103772337B (zh) | 大孔吸附树脂辅助各种苷类水解制备其苷元、次生苷的方法 | |
Yuan et al. | Structural characterisation and immunomodulatory activity of a neutral polysaccharide from Sambucus adnata Wall | |
CN106967142B (zh) | 一种同时提取罗汉果甜苷v、ⅵ和11-o基苷v的方法 | |
CN105218611B (zh) | 第20碳羟基脱水的人参稀有皂苷和苷元的制备方法 | |
CN103923149A (zh) | 绞股蓝皂苷XLV Ed及其制备方法 | |
CN1982438A (zh) | 一株芽孢杆菌及用其制备单糖链人参皂苷及苷元的方法 | |
CN100584856C (zh) | 一种常春藤皂苷、其制备方法及其制备抗肿瘤药物的用途 | |
Jia et al. | Triterpenoid saponins from Caryophyllaceae family | |
Borjigin et al. | Extraction, purification, structural characterization and biological activity of polysaccharides from Fritillaria: A review | |
CN107501376B (zh) | 金属离子催化制备人参25碳-羟基苷元和稀有皂苷的方法 | |
CN110256512A (zh) | 一种从矮生二裂委陵菜中提取的α-葡萄糖苷酶抑制剂 | |
CN102492666A (zh) | 一种酶制剂及其用于提取葛根总黄酮的应用和方法 | |
CN107929544B (zh) | 白及属植物中militarine部位及单体的制备方法及其应用 | |
CN103059089B (zh) | 鲜葡萄汁催化下水解原人参二醇组皂苷制备次级人参皂苷Rg3的方法 | |
CN106589158A (zh) | 一种山芝麻多糖及其制备方法、应用 | |
Zong et al. | Optimized acid hydrolysis conditions for better characterization the structure of inulin-type fructan from Polygonatum sibiricum | |
Chen et al. | Isolation and structure elucidation of hypoglycemic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180514 Address after: 300000 Tianjin Binhai high tech Zone, Binhai science and Technology Park, 19 Kangtai Avenue, 19. Patentee after: Tianjin Tian Guang Guanghua Health Technology Co., Ltd. Address before: 116000 College of bioengineering, Dalian Polytechnic University, Ganjingzi No. 1 Light Industrial Park, Ganjingzi, Dalian Patentee before: Jin Fengxie |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: 300457 Building 19, 59 Kangtai Avenue, Binhai Science Park, Binhai New District, Tianjin Patentee after: Sunflower Pharmaceutical Group (Tianjin) Pharmaceutical Research Institute Co., Ltd. Address before: 300000 Tianjin Binhai high tech Zone, Binhai science and Technology Park, 19 Kangtai Avenue, 19. Patentee before: Tianjin Tian Guang Guanghua Health Technology Co., Ltd. |
|
CP03 | Change of name, title or address |